We serve N-(9-acetyl-6-oxo-3H-purin-2-yl)acetamide CAS:3056-33-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Contact us for information like N-(9-Acetyl-6-oxo-6,9-dihydro-1H-purin-2-yl)acetamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N2,9-Diacetylguanine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-(9-Acetyl-6-oxo-6,9-dihydro-1H-purin-2-yl)acetamide Use and application,2-Acetamido-9-acetyl-6-oxopurine technical grade,usp/ep/jp grade.
Related News: Refers to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs or innovative drugs). It mainly meets the needs of international original research drug companies and emerging biopharmaceutical companies for innovative drugs at various stages of clinical research, registration approval and commercialization of drugs. Contains advanced intermediates used in the manufacture of this drug substance that need to be regulated by regulatory authorities.2-Fluoro-6-nitro-n-phenylbenzamide manufacturer Refers to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs or innovative drugs). It mainly meets the needs of international original research drug companies and emerging biopharmaceutical companies for innovative drugs at various stages of clinical research, registration approval and commercialization of drugs. Contains advanced intermediates used in the manufacture of this drug substance that need to be regulated by regulatory authorities.1,2,3-Trifluorobenzene supplier Prime Minister Scott Morrison said Saturday that all travelers from mainland China allowed into Australia had to be quarantined for 14 days.1-bromobut-2-yne vendor Prime Minister Scott Morrison said Saturday that all travelers from mainland China allowed into Australia had to be quarantined for 14 days.“Inceptua Medicines Access is delighted to be selected as Onconova’s partner for the Pre-approval Access Program for rigosertib.
